Lantern Pharma Inc. (NASDAQ:LTRN) Q4 2024 Earnings Call Transcript March 27, 2025
Lantern Pharma Inc. misses on earnings expectations. Reported EPS is $-0.54 EPS, expectations were $-0.51.
Operator: Good afternoon, and welcome to our Fourth Quarter and Year End 2024 Earnings Call. As a reminder, this call is being recorded, and all attendees are in a listen-only mode. We will open the call for questions-and-answers after our management’s presentation. A webcast replay of today’s conference...
